BACK TO THE WIRE
FUNDING◐ DEVELOPINGI · Intelligence◆ Concentrating

Proximal Ventures launches $27.5M fund for AI drug-development startups

Nov 10, 2026SOURCE: techcrunch.com
SO WHAT

Within the window, this funds the next layer of model-enabled discovery; the strategic risk is whether ownership consolidates faster than access, steering toward feudal control.

A new vehicle bets on AI accelerating pharma discovery, with proceeds clustering around early builders. In the inversion, the business shifts from wet-lab labor to intelligence throughput—while the old system judges value by scarcity.

This is Negative Resistance’s reframed reading of a reported signal. The headline and analysis above are our interpretation through the thousand-day-window lens. The original reporting lives at the source linked above.